TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
Wei CY, Wang L, Zhu MX, Deng XY, Wang DH, Zhang SM, Ying JH, Yuan X, Wang Q, Xuan TF, He AQ, Qi FZ, Gu JY.
Wei CY, et al.
J Exp Clin Cancer Res. 2019 Mar 28;38(1):137. doi: 10.1186/s13046-019-1138-7.
J Exp Clin Cancer Res. 2019.
PMID: 30922374
Free PMC article.